Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ZK International (ZKIN) Cash & Equivalents (2016 - 2025)

ZK International (ZKIN) has disclosed Cash & Equivalents for 11 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 62.27% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a 62.27% decrease, with the full-year FY2025 number at $1.5 million, down 62.27% from a year prior.
  • Cash & Equivalents was $1.5 million for Q3 2025 at ZK International, down from $4.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $4.0 million in Q3 2024 to a low of $50995.0 in Q3 2023.
  • A 5-year average of $1.2 million and a median of $101992.0 in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 97.93% in 2021, then soared 7762.31% in 2024.
  • ZK International's Cash & Equivalents stood at $77906.0 in 2021, then skyrocketed by 30.92% to $101992.0 in 2022, then crashed by 50.0% to $50995.0 in 2023, then skyrocketed by 7762.31% to $4.0 million in 2024, then plummeted by 62.27% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for ZKIN's Cash & Equivalents are $1.5 million (Q3 2025), $4.0 million (Q3 2024), and $50995.0 (Q3 2023).